WUHAN, CHINA - JANUARY 22: (CHINA OUT) Security personnel check the temperature of passengers in the Wharf at the Yangtze River on January 22, 2020 in Wuhan, Hubei province, China. A new infectious coronavirus known as "2019-nCoV" was discovered in Wuhan as the number of cases rose to over 400 in mainland China.
The outcomes of clinical trials conducted by medical authorities in China suggest that a drug used in Japan to treat new strands of the influenza appears to be effective in coronavirus patients.
Zhang Xinmin, an official at China’s science and technology ministry, told reporters on Tuesday that the drug favipiravir has “a high degree of safety and is clearly effective in treatment.”
Patients who were given the medicine during trials turned negative after an average of four days after contracting the virus. In comparison, those who were not treated with the drug turned negative after an average of 11 days.
Researchers also found that the lung condition of patients improved about 91% of the patients who were given the drug, compared to 62% of patients who did not take it.
Results of the trials suggest that the drug is not effective in treating patients with more severe symptoms of the virus.
The trials involved 340 patients in total.
Fujifilm Toyama Chemical, which developed favipiravir in 2014, has declined to comment.
With Lamar’s diss-track and Drake’s pedophilic tendencies officially recognized by the awards show, some people…
NFL star Saquon Barkley has revealed that he is engaged to his longtime girlfriend, Anna Congdon, as he…
Selena Gomez has become the latest high-profile target of the Trump administration following her public criticism…
The tour is slated to kick off in Arizona on May 13, and conclude in…
Rogan claimed that he believes Harris must regret the decision not to commit, as Trump…
The documents further accuse Lively of refusing to attend fittings at the production office and…